Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Start Ig: Antibiotics vs Immunoglobulin for Infection Prevention in Blood Cancers
NCT07202078Phase 3Recruiting
- Sponsor
- Monash University
- Start
- May 2025
- Primary completion
- Mar 2027
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimethoprim + sulfamethoxazole, intravenous immunoglobulin G in Infection, sponsored by Monash University. Started May 2025; status: recruiting.
02
Drugs
trimethoprim + sulfamethoxazoleintravenous immunoglobulin G
03
Conditions
Infection
Beyond the preview
Go deeper on NCT07202078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07202078.